ArticleTherapeutic advances in medical oncology2025
Platelet-to-lymphocyte ratio as a prognostic biomarker in patients with human epidermal growth factor receptor 2-negative breast cancer undergoing taxane-carboplatin-based neoadjuvant chemotherapy.
Qiuyan Huang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.